TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Guest Editorial: Thoughts on Overusing Radiation in Medicine And Redeeming that Whole Body Scan Coupon March 1, 2013
TCL Archive Patient Advocacy: Survivorship Programs Win Funds To form Model Programs December 13, 1996
TCL Archive New Model Provides Better Estimate of Breast Cancer Risk in Black Women. November 30, 2007
TCL Archive Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage August 7, 1998